Background and Aims:In this retrospective study our aim was to find the prevalance of heterotopic gastric mucosa, evaluate its clinical importance, and study the endoscopic findings associated with heterotopic gastric mucosa in patients with diffrerent indications for gastrointestinal endoscopy. Materials and Methods:This study comprised 3.384 patients who were referred to our hospital's gastroenterology department with different complaints and to whom upper gastrointestinal endoscopy was performed during 2009-2013. Heterotopic gastric mucosa prevalance, endoscopic findings associated with heterotopic gastric mucosa, the main complaints of patients with heterotopic gastric mucosa and endoscopic biopsy findings were recorded. Results:Out of 3.384 patients, heterotopic gastric mucosa was found in 86 (2.5%) patients. Endoscopic findings associated with heterotopic gastric mucosa was as follows: Reflux esophagitis in 22 (25.5%) patients; lower esophageal sphincter dysfunction in 7 (8.1%) patients; hiatal hernia in 10 (11.6%) patients; Barrett esophagus in 5 (5.8%) patients; cardiac cancer in 1 (1.1%) patient; esophageal gastrointestinal stromal tumor in 1 (1.1%) patient; peptic ulcer in 7 (%8.1) patients; and gastritis in 74 (86%) patients. The primary complaints of patients with heterotopic gastric mucosa included: retrosternal pain and/ or regurgitation in 28 (32.5%) patients; dysphagia in 17(19.7%) patients; dyspepsia in 35 (40.6%) patients; and laryngopharengial reflux symptoms in 6 (6.9%) patients. The endoscopic biopsy of antrum mucosa revealed that 26 (30%) patients had Helicobacter pyloriinfection. Conclusion:Heterotopic gastric mucosa prevalance was 2.5% in our patients. Half of our patients presented with dysphagia or reflux symptoms. Barrett esophagus prevalance was 5.8%, which is relatively higher, supporting the relationship between heterotopic gastric mucosa and Barrett esophagus.
Background and Aims:In this retrospective study our aim was to find the prevalence of heterotopic gastric mucosa, evaluate its clinical importance, and study the endoscopic findings associated with heterotopic gastric mucosa in patients with diffrerent indications for gastrointestinal endoscopy. Materials and Methods:This study comprised 3,384 patients who were referred to our hospital's gastroenterology department with different complaints and to whom upper gastrointestinal endoscopy was performed during 2009-2013. Heterotopic gastric mucosa prevalance, endoscopic findings associated with heterotopic gastric mucosa, the main complaints of patients with heterotopic gastric mucosa and endoscopic biopsy findings were recorded. Results: out of 3. 384 patients, heterotopic gastric mucosa was found in 86 (2.5%) patients. Endoscopic findings associated with heterotopic gastric mucosa was as follows: Reflux esophagitis in 22 (25.5%) patients; lower esophageal sphincter dysfunction in 7 (8.1%) patients; hiatal hernia in 10 (11.6%) patients; Barrett esophagus in 5 (5.8%) patients; heart cancer in 1 (1.1%) patients; esophageal gastrointestinal stromal tumor in 1 (1.1%) patients; peptic ulcer in 7 (8.1%) patients; and gastritis in 74 (86%) patients. The primary complaints of patients with heterotopic gastric mucosa included: retrosternal pain and/or regurgitation in 28 (32.5%) patients; dysphagia in 17(19.7%) patients; dyspepsia in 35 (40.6%) patients; and laryngopharengial reflux symptoms in 6 (6.9%) patients. The endoscopic biopsy of antrum mucosa revealed that 26 (30%) patients had Helicobacter pyloriinfection. Conclusion:Heterotopic gastric mucosa prevalence was 2.5% in our patients. Half of our patients presented with dysphagia or reflux symptoms. Barrett esophagus prevalence was 5.8%, which is relatively higher, supporting the relationship between heterotopic gastric mucosa and Barrett esophagus.
Alan : Sağlık Bilimleri
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|